non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients#18603ClinicalTrials.gov
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer#18604ClinicalTrials.gov
• Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer#18606ClinicalTrials.gov
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial#28299ClinicalTrials.gov
• Modifying Your Diet to Support Muscle During Cancer Treatment.#67881ClinicalTrials.gov
• Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer#67905ClinicalTrials.gov
• Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)#121328ClinicalTrials.gov
• ARGONAUT: Stool and Blood Sample Bank for Cancer Patients#121332ClinicalTrials.gov
• Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients#121369ClinicalTrials.gov
• A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors#123471ClinicalTrials.gov
• A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC#325288ClinicalTrials.gov
• ITIL-168 in Advanced Solid Tumors#325305ClinicalTrials.gov
• The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy#332762ClinicalTrials.gov
• Cardiopulmonary Toxicity of Thoracic Radiotherapy#332854ClinicalTrials.gov
• IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy#343834ClinicalTrials.gov
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer#343837ClinicalTrials.gov
• Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer#346911ClinicalTrials.gov
• CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma#346917ClinicalTrials.gov
• Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer#346988ClinicalTrials.gov
• D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)#349957ClinicalTrials.gov
• Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer#349972ClinicalTrials.gov
• Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients#353282ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies#353286ClinicalTrials.gov
• Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)#353288ClinicalTrials.gov
• A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer#356468ClinicalTrials.gov
• Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study#363600ClinicalTrials.gov
• Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy#363612ClinicalTrials.gov
• Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer#363615ClinicalTrials.gov
• Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes#366577ClinicalTrials.gov
• Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC#366609ClinicalTrials.gov
• Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis#7722HAL (France)

Related topics